Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04887961
Title Reprab Study: PLD + Trabectedin Rechallenge (MITO36)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Indications

peritoneal carcinoma

ovary epithelial cancer

fallopian tube cancer

Therapies

Pegylated liposomal-doxorubicin + Trabectedin

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.